Table 1.
Baseline Characteristics of 313 Patients Stratified by Primary Site Surgery
| no surgery or unknown | Wedge or segmental resection or Lobectomy | Hepatectomy and or transplant | p.overall | |
|---|---|---|---|---|
| N=229 | N=58 | N=26 | ||
| Age | 55.0 [39.0;65.0] | 53.5 [37.2;62.8] | 45.0 [38.2;54.2] | 0.164 |
| Sex: | 0.301 | |||
| Male | 107 (46.7%) | 23 (39.7%) | 15 (57.7%) | |
| Female | 122 (53.3%) | 35 (60.3%) | 11 (42.3%) | |
| Year of diagnosis: | 0.454 | |||
| before and in 2010 | 106 (46.3%) | 23 (39.7%) | 14 (53.8%) | |
| after 2010 | 123 (53.7%) | 35 (60.3%) | 12 (46.2%) | |
| Race: | 0.858 | |||
| White | 183 (79.9%) | 48 (82.8%) | 22 (84.6%) | |
| others | 46 (20.1%) | 10 (17.2%) | 4 (15.4%) | |
| Combined Summary Stage: | ||||
| Localized | 49 (21.4%) | 34 (58.6%) | 6 (23.1%) | |
| Regional | 25 (10.9%) | 9 (15.5%) | 12 (46.2%) | |
| Distant | 91 (39.7%) | 11 (19.0%) | 6 (23.1%) | |
| Unknown/unstaged | 64 (27.9%) | 4 (6.90%) | 2 (7.69%) | |
| Radiation recode: | 0.450 | |||
| None or Unknown | 221 (96.5%) | 56 (96.6%) | 24 (92.3%) | |
| radiation performed | 8 (3.49%) | 2 (3.45%) | 2 (7.69%) | |
| Chemotherapy recode: | 0.120 | |||
| No or Unknown | 161 (70.3%) | 48 (82.8%) | 17 (65.4%) | |
| Yes | 68 (29.7%) | 10 (17.2%) | 9 (34.6%) | |
| Systemic Sur Seq: | <0.001 | |||
| no Systemic therapy after and before surgery | 225 (98.3%) | 50 (86.2%) | 19 (73.1%) | |
| Systemic therapy after or before surgery | 4 (1.75%) | 8 (13.8%) | 7 (26.9%) | |
| Sequence number: | 0.806 | |||
| One primary only | 187 (81.7%) | 47 (81.0%) | 20 (76.9%) | |
| Over one | 42 (18.3%) | 11 (19.0%) | 6 (23.1%) | |
| Median_household_income_inflation_adj_to_2021: | 0.807 | |||
| below $70000 | 113 (49.3%) | 26 (44.8%) | 12 (46.2%) | |
| more than $70000 | 116 (50.7%) | 32 (55.2%) | 14 (53.8%) | |
| Rural Urban Continuum Code: | 0.441 | |||
| Metropolitan (1 million+) | 161 (70.3%) | 37 (63.8%) | 20 (76.9%) | |
| Other metropolitan or non-metropolitan | 68 (29.7%) | 21 (36.2%) | 6 (23.1%) | |